KineMed

KineMed, Inc., a privately held biotechnology company based in Emeryville, CA, is a leader in translational and personalized medicine. KineMed uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases. KineMed is developing a focused, high-quality pipeline of its own in-licensed compounds.